Showing 1 - 2 results of 2 for search 'Mazhar Haque', query time: 0.01s Refine Results
  1. 1
    In a ‘Real-World’, Clinic-Based Community Setting, Sorafenib Dose of 400 mg/day is as Effective as Standard Dose of 800 mg/day in Patients with Advanced Hepatocellular Carcimona, with Better Tolerance and Similar Survival

    In a ‘Real-World’, Clinic-Based Community Setting, Sorafenib Dose of 400 mg/day is as Effective as Standard Dose of 800 mg/day in Patients with Advanced Hepatocellular Carcimona, w... by Alexandra Shingina, Al Moutaz Hashim, Mazhar Haque, Michael Suen, Eric M Yoshida, Sharlene Gill, Fergal Donnellan, Alan A Weiss

    Published 2013-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Prevalence, risk factors and metabolic profile of the non-obese and obese non-alcoholic fatty liver disease in a rural community of South Asia

    Prevalence, risk factors and metabolic profile of the non-obese and obese non-alcoholic fatty liver disease in a rural community of South Asia by M Masudur Rahman, Mazhar Haque, Md Golam Kibria, Hasina Begum, Nigar Sultana, Mahfuza Akhter, A H M Rowshon, Faruqe Ahmed, Mahmud Hasan

    Published 2020-12-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: